🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
We define refractory nasopharyngeal carcinoma as the following: recurrence ...
Status
Unknown
Location
Department of Radiation Oncology, Sun Yat-Sen University Cancer Center
Start Date
2015-07
Trial ID
NCT02590133
Treatments Being Tested
The primary objectives of this control, single-center clinical study of End...
Status
Unknown
Location
Cancer Hospital of Xinjiang Medical University
Start Date
2013-08
Trial ID
NCT02008422
Treatments Being Tested
Explore the efficacy and safety of the treatment of Endostar continuous int...
Status
Unknown
Location
Jinling Hospital
Start Date
2015-03
Trial ID
NCT02513342
To study safety and efficacy of intravenous pump of recombinant human endos...
Status
Unknown
Location
Sichuan Provincial People Hospital
Start Date
2018-07-01
Trial ID
NCT03577392
Treatments Being Tested
Here we are going to find a method by using available multiple drugs includ...
Status
Unknown
Location
Peking University Third Hospital
Start Date
2014-01
Trial ID
NCT02350361
Treatments Being Tested
FOLFOX4 plus Avastin has been suggested as firstline regimen for advanced c...
Status
Unknown
Location
The Affiliated Changzhou Tumor Hospital of Suzhou University
Start Date
2008-10
Trial ID
NCT00813137
Treatments Being Tested
This trial is an open-label, randomized, multicenter study to explore Endos...
Status
Unknown
Location
Lan Mu
Start Date
2021-07-30
Trial ID
NCT04942301
Treatments Being Tested
The purpose of this study is to investigate whether endostar (recombinant h...
Status
Completed
Location
Department of GI Oncology, Peking University, School of Oncology
Start Date
2008-11
Trial ID
NCT00842491
Treatments Being Tested
This phase Ⅱ study was designed to evaluate the efficacy and safety of endo...
Status
Completed
Location
Sun Yat-sen University Cancer Center
Start Date
2015-01
Trial ID
NCT02350517
Treatments Being Tested
This is a randomized, double-blind, placebo-controlled (2: 1), multicenter ...
Status
Completed
Location
Tianjin Medical University Cancer Hospital & Institute
Start Date
2017-05-01
Trial ID
NCT03121833
Treatments Being Tested